Jose Montoya

Jose Montoya is an Infectious disease doctor and Professor of Medicine (Infectious Diseases and Geographic Medicine) at Stanford University Medical Center and heads the Stanford ME/CFS Initiative. His special areas of clinical focus include: Chronic Fatigue Syndrome, Infectious Disease, Toxoplasmosis, Infection in the setting of solid organ transplantation, and Infection as a trigger of chronic diseases. He is considered one of the foremost experts of ME/CFS and has been invited to serve on many government and institutional committees regarding ME/CFS. He is a frequent researcher and conference speaker.

Education

 * 1985, Medical Education:Universidad Del Valle, Colombia
 * 1988, Internship:Tulane University School of Medicine
 * 1990, Residency:Tulane University School of Medicine, Louisiana, US
 * 1994, Fellowship:Stanford University School of Medicine,California, US

Clinical practice
Dr. Montoya and his team at the Stanford ME/CFS Initiative have short term goals of Patient Care, Research and Discovery, and Education. They, also, have a long term goal of establishing an inpatient center, apart from a hospital where patients with chronic conditions could receive long-term treatment.

At present there is a waiting list to see Dr. Montoya. If you would like to be placed on the waiting list, please contact the New Patient Coordinator at (650) 736-5200.

Clinic address

 * 2nd Floor of Hoover Pavilion
 * 211 Quarry Road
 * Palo Alto, CA 94304.
 * Phone: (650) 736-5200.

Awards

 * 1988, Outstanding Intern Award, Department of Medicine, Tulane University School of Medicine
 * 1990, The Owl Club Award for Outstanding Clinical Teaching, Tulane University School of Medicine
 * 1990, The Department of Medicine Outstanding Teaching Award, Tulane University School of Medicine
 * 1990, Outstanding Senior Resident Awar, Department of Medicine, Tulane University School of Medicine
 * 1995, The Franklin G. Ebaugh, Jr. Award for Advising Medical Students, Stanford University School of Medicine
 * 1995, The Henry J. Kaiser Award for Excellence in Clinical Teaching, Stanford University School of Medicine
 * 1997, The Arthur L. Bloomfield Award for Excellence in the Teaching of Clinical Medicine, Stanford University School of Medicine
 * 1998, The David A. Rytand Teaching Award for Excellence in Clinical Teaching, Department of Medicine, Stanford University School of Medicine
 * 2000, The Kenneth Vosti Teaching Award for Excellence in Teaching, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine
 * 2001, The David A. Rytand Teaching Award for Excellence in Clinical Teaching., Department of Medicine, Stanford University School of Medicine
 * 2002, The Kenneth Vosti Teaching Award for Excellence in Teaching, Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine
 * 2003, Chief Residents Teaching Award for exemplary teaching at Stanford Resident's report, Department of Medicine, Stanford University School of Medicine
 * 2011, The Arthur L. Bloomfield Award for Excellence in the Teaching of Clinical Medicine, Stanford University School of Medicine
 * 2011, Fellow of the Infectious Diseases Society of America (FIDSA), Infectious Diseases Society of America
 * 2011, Fellow of the American College of Physicians (FACP), American College of Physicians
 * 2013, Selected as one of the 100 Colombians who have exceled abroad, 2013 Edition., 100 Colombianos en el exterior

IOM Committee on Diagnostic Criteria for ME/CFS
Dr Montoya was a reviewer for the 2015 report produced by the Institute of Medicine's Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

ME/CFS Collaborative Research Center at Stanford University
Dr. Montoya is a member of the Working Group which offers their expertise and resources to the ME/CFS Collaborative Research Center at Stanford University.

ME/CFS Common Data Element (CDE) Project
Co-chair with Dr. Anthony Komaroff for the Baseline/Covariate Working Group and co-chair with Kimberly Sullivan, PhD of the Neurologic/Cognitive/CNS Imaging Working Group for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control & Prevention.

Notable Studies

 * 2006, Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. (Abstract)
 * 2012, Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers
 * 2012, A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus (Full Text)
 * 2013, Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology
 * 2013, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Valganciclovir in a Subset of Patients With Chronic Fatigue Syndrome
 * 2014, Conference paper, EEG peak alpha frequency is associated with chronic fatigue syndrome: A case-control observational study (Full Text)
 * 2014 - Conference paper, Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Abstract, full text on request)
 * 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness (Full Text)
 * 2017, Cytokine signature associated with disease severity in chronic fatigue syndrome patients (Full Text)
 * 2017, Patients diagnosed with Myalgic encephalomyelitis/chronic fatigue syndrome also fit systemic exertion intolerance disease criteria
 * 2017, Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome (Full Text)
 * 2015, Right Arcuate Fasciculus Abnormality in Chronic Fatigue Syndrome
 * 2018 - Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome (Abstract)
 * 2018, Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey (Full Text)
 * 2018, Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
 * 2018, KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A prospective, randomized trial (Full Text)
 * 2018, Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics (Full Text)
 * 2019, Onset patterns and course of myalgic encephalomyelitis/ chronic fatigue syndrome

Talks & Interviews

 * Mar 2011, Stanford's Dr. Jose Montoya on Chronic Fatigue Syndrome
 * Aug 2014, ME/CFS Alert Episode 65: Dr. Jose Montoya Interviewed by Deborah Waroff
 * Jul 26 2016, Stanford leads fight against chronic fatigue
 * 2016, Exercise testing highlights differences in cytokine profile and network between patients with chronic fatigue syndrome and healthy sedentary participants and A profile of circulating cytokines is associated with disease severity in chronic fatigue syndrome patients
 * 2017, The author of Truth to Power interviews the leading Chronic Fatigue Syndrome researcher
 * 2018, Science for ME video Q&A with Dr José G. Montoya, 16th January 2018

Notable quotes
Back in 2005, while attending a conference on toxoplasmosis in Paris, Montoya told his mentor that he wanted to research ME/CFS. His mentor scoffed at the idea, pointing to a homeless person lying in a Parisian gutter. 'That’s going to be you if you go into chronic fatigue research,' the mentor told him.

Online presence

 * Jose G. Montoya Stanford Medicine Profile
 * Stanford ME/CFS Initiative

Learn more

 * 2014, Brains of People With Chronic Fatigue Syndrome Offer Clues About Disorder - New York Times: Well (2014)
 * 2016, Stanford lead fight against chronic fatigue syndrome
 * 2016, Will 2016 Finally be Montoya's Year? Taking Stock of the Stanford ME/CFS Initiative